Arch Venture Partners has taken the lid off its big bet on neuroscience. Having quietly put the startup together over the past 18 months, Thursday Arch unveiled Neumora Therapeuticsa biotech that starts life with $500 million, a collaboration with Amgen and a pipeline of eight prospects.
Neumora represents a test of the idea that neuroscience is on the cusp of the sort of rapid progress that has transformed oncology in recent years. If Neumora is right, recent advances in genomics and neurobiology have set the stage for more targeted modulation of the underlying biology of specific brain diseases, just as the oncology field has gone from targeting organs to zeroing in on molecularly defined diseases.
We recognized an opportunity to build a proprietary toolbox of state-of-the-art neural network technologies, which uniquely positions us to pioneer a new era in precision medicines for brain diseases by integrating data science and neuroscience, Lori Lyons-Williams, chief operating officer at Neumora, said.
Armed with the platform, Neumora aims to match the right patients to targeted therapeutics, Lyons-Williams said, enabling it to de-risk clinical trials and improve outcomes for patients. Unlike most newly unveiled biotechs, Neumora is already in a position to start putting its ideas to the test in the clinic.
RELATED: As Amgen zeroes in on cancer, neuroscience pipeline under the ax
The startup begins life with a pipeline of eight candidates, two of which are in the clinic, and more than $500 million to fund their development. Most of the money comes from an Arch-led syndicate.
Some of the assets, targeting casein kinase 1 delta and glucocerebrosidase, and $100 million of the cash come from Amgen, which pulled out of neuroscience R&D in 2019. The Big Biotechs retreat from the hard-to-crack therapeutic area opened the door to a deal with Neumora. Amgen will use its deCODE genetics and human data research capabilities to feed insights into Neumoras precision neuroscience platform.
Neumora put together the rest of the pipeline by rolling up privately held companies including BlackThorn Therapeutics. Arch led a $40 million series A round in BlackThorn in 2016 and went on to participate in a $76 million series B in 2019. The rounds positioned BlackThorn, under the leadership of a team featuring Paul Berns, to advance targeted therapeutics for mental health.
BlackThorn is now part of Neumora, and Berns is CEO of the combined company, slotting in at the head of a C-suite that features John Dunlop, Ph.D., formerly of Amgen, in the chief scientific officer role. Other posts are filled by former employees of companies including Alexion and BlackThorn. As it stands, BlackThorn is still listed as the sponsor of a phase 2 clinical trial that is testing kappa opioid receptor antagonist BTRX-335140 in patients with major depressive disorder. The 180-subject study is scheduled to wrap up next summer, according to ClinicalTrials.gov.
RELATED: Fierce 15 2017 | BlackThorn Therapeutics
BTRX-335140, now known as NMRA-140, is joined in Neumoras clinical-phase pipeline by NMRA-511, a selective V1aR antagonist that is in phase 1 development as a treatment of anxiety disorders. Neumoras preclinical pipeline addresses sleep, neuropsychiatric and neurodegenerative disorders.
Building a pipeline that has mental health programs alongside drugs targeting neurodegenerative diseases sets Neumora apart from most of its predecessors. However, while acknowledging that the industry has historically kept neuropsychiatric disorders and neurodegenerative diseases separate, Lyons-Williams thinks current knowledge supports a more unified approach.
The reality is that these are all diseases of one organ, the brain, and there are mechanistic overlaps and comorbidities across these diseases. We believe our multi-modal data science approach captures unique insights across a range of disease drivers including genetic, imaging and clinical that can be applicable across brain diseases, Lyons-Williams said.
Neumora will soon be in a position to start delivering some early wins, or losses. Data drops on the two clinical programs are planned for 2022 and 2023, Lyons-Williams said, and multiple INDs are on the schedule for the next few years. Neumora plans to advance the pipeline prospects while building out its platform, including by adding more data sets and expanding its data science efforts.
Go here to see the original:
Meet Neumora, Arch's $500M, Amgen-partnered play for the targeted future of neuroscience R&D - FierceBiotech
- The 15 most popular psychology and neuroscience studies in 2024 - PsyPost - January 1st, 2025 [January 1st, 2025]
- The 'lizard brain' lie: How neuroscience demolished the greatest mind myth - BBC Science Focus - January 1st, 2025 [January 1st, 2025]
- Revolutionizing Brain Diagnostics with Light and AI - Neuroscience News - January 1st, 2025 [January 1st, 2025]
- How Early Experiences Shape Genes, Brain Health, and Resilience - Neuroscience News - January 1st, 2025 [January 1st, 2025]
- A nation exhausted: The neuroscience of why Americans are tuning out political news - Indiana Capital Chronicle - January 1st, 2025 [January 1st, 2025]
- Lithium Restores Brain Function and Behavior in Autism - Neuroscience News - January 1st, 2025 [January 1st, 2025]
- Partners in Diversity presents the science of belonging: exploring the neuroscience of inclusion - Here is Oregon - January 1st, 2025 [January 1st, 2025]
- Classical vs. Operant Conditioning: The Brain's Memory Tug-of-War - Neuroscience News - January 1st, 2025 [January 1st, 2025]
- The Personality Gap Between Singles and the Partnered - Neuroscience News - January 1st, 2025 [January 1st, 2025]
- The Neuroscience Behind Vermeers Girl and Its Hypnotic Power - ZME Science - January 1st, 2025 [January 1st, 2025]
- Serotonin, GABA, and Dopamine Drive Hunger and Feeding - Neuroscience News - December 23rd, 2024 [December 23rd, 2024]
- A nation exhausted: The neuroscience of why Americans are tuning out politics - The Conversation - December 23rd, 2024 [December 23rd, 2024]
- UNO Goalie and Neuroscience Grad Shines in Her Athletic and Academic Aspirations - University of Nebraska Omaha - December 23rd, 2024 [December 23rd, 2024]
- Neuroscience Major Seeks to Bridge the Generation Gap, Help Alzheimers Patients - Pomona College - December 23rd, 2024 [December 23rd, 2024]
- Spectrum 2024: Year in review - The Transmitter: Neuroscience News and Perspectives - December 23rd, 2024 [December 23rd, 2024]
- Say what? The Transmitters top quotes of 2024 - The Transmitter: Neuroscience News and Perspectives - December 23rd, 2024 [December 23rd, 2024]
- Targeted or Broadcast? How the Brain Processes Visual Information - Neuroscience News - December 23rd, 2024 [December 23rd, 2024]
- 70 Is the New 60: Age Related Declines Slowing in Older People - Neuroscience News - December 23rd, 2024 [December 23rd, 2024]
- Breathing Rhythms During Sleep Strengthen Memory Consolidation - Neuroscience News - December 23rd, 2024 [December 23rd, 2024]
- How our brains think: Exploring the world of neuroscience at the Yale Peabody Museum - Connecticut Public - December 23rd, 2024 [December 23rd, 2024]
- Assembloids illuminate circuit-level changes linked to autism, neurodevelopment - The Transmitter: Neuroscience News and Perspectives - December 23rd, 2024 [December 23rd, 2024]
- Mapping the Brain's Response to Social Rejection - Neuroscience News - December 9th, 2024 [December 9th, 2024]
- An eye for science: Q&A with Bryan W. Jones - The Transmitter: Neuroscience News and Perspectives - December 9th, 2024 [December 9th, 2024]
- Short Sleep and High Blood Pressure Linked to Brain Aging - Neuroscience News - December 9th, 2024 [December 9th, 2024]
- Neighborhood Disadvantage Linked to Cognitive Health Risks - Neuroscience News - December 9th, 2024 [December 9th, 2024]
- Psychosis Risk Tied to Heavy Cannabis Use and Genetic Factors - Neuroscience News - December 9th, 2024 [December 9th, 2024]
- Most Teens Recover From Long Covid Within Two Years - Neuroscience News - December 9th, 2024 [December 9th, 2024]
- Opportunities and challenges of single-cell and spatially resolved genomics methods for neuroscience discovery - Nature.com - December 9th, 2024 [December 9th, 2024]
- How Evolution Shaped the Brains Understanding of Numbers - Neuroscience News - December 9th, 2024 [December 9th, 2024]
- Neuroscience Study Aboard Cunard's Queen Mary 2 Reveals Cognitive Benefits of Slow Travel at Sea - PR Newswire - November 28th, 2024 [November 28th, 2024]
- How Expectations Shape Our Gaze in a Changing World - Neuroscience News - November 28th, 2024 [November 28th, 2024]
- To keep or not to keep: Neurophysiologys data dilemma - The Transmitter: Neuroscience News and Perspectives - November 28th, 2024 [November 28th, 2024]
- Does Alcohol Consumption Contribute to Hair Loss? - Neuroscience News - November 28th, 2024 [November 28th, 2024]
- Brains Traffic Controllers Hold Key to Learning and Memory - Neuroscience News - November 28th, 2024 [November 28th, 2024]
- Despite Neuroscience Setback, AbbVie Has Strong Recovery Ahead (ABBV) - Seeking Alpha - November 28th, 2024 [November 28th, 2024]
- Neuroscientists reeling from past cuts advocate for more BRAIN Initiative funding - The Transmitter: Neuroscience News and Perspectives - November 28th, 2024 [November 28th, 2024]
- Want Better Habits? Neuroscience Says This Is How to Train Your Brain - Inc. - November 28th, 2024 [November 28th, 2024]
- Dopamine and Serotonin Work in Opposition for Effective Learning - Neuroscience News - November 28th, 2024 [November 28th, 2024]
- Cunard Proves the Healing Power of Ocean Travel with Breakthrough Neuroscience Research - Travel And Tour World - November 28th, 2024 [November 28th, 2024]
- Bridging the Gap between Meditation, Neuroscience, and the Soul - openPR - November 28th, 2024 [November 28th, 2024]
- Animal Characters in Childrens Books Boost Theory of Mind - Neuroscience News - November 28th, 2024 [November 28th, 2024]
- Emotional Struggles and Tantrums in Preschoolers Linked to ADHD - Neuroscience News - November 28th, 2024 [November 28th, 2024]
- Neuroscience Says This Simple Habit Improves Cognitive Health and Makes Your Brain Act Younger - Inc. - November 20th, 2024 [November 20th, 2024]
- Premature declarations on animal consciousness hinder progress - The Transmitter: Neuroscience News and Perspectives - November 20th, 2024 [November 20th, 2024]
- Medtronic Q2 Earnings: Diabetes And Neuroscience Revenue Boost Growth, Raises Annual Outlook - Yahoo Finance - November 20th, 2024 [November 20th, 2024]
- Trace Neuroscience Nets $101M in Series A Funding for ALS, Dementia Therapy Development - Senior Housing News - November 20th, 2024 [November 20th, 2024]
- How to be a multidisciplinary neuroscientist - The Transmitter: Neuroscience News and Perspectives - November 20th, 2024 [November 20th, 2024]
- Neuroscience Market Expected to Reach USD 71.0 Billion by - GlobeNewswire - November 20th, 2024 [November 20th, 2024]
- Finger-Prick Test Brings Alzheimers Detection Closer to Everyone - Neuroscience News - November 20th, 2024 [November 20th, 2024]
- Dual-Gene Therapy Shows Promise for Hearing and Vision Loss - Neuroscience News - November 20th, 2024 [November 20th, 2024]
- Robots Help Unlock the Mystery of Human Sense of Self - Neuroscience News - November 20th, 2024 [November 20th, 2024]
- The neuroscience of sleep - University of South Carolina - November 20th, 2024 [November 20th, 2024]
- Stress warps fear memories in multiple ways - The Transmitter: Neuroscience News and Perspectives - November 20th, 2024 [November 20th, 2024]
- Mental Exhaustion Drives Aggressive Behavior - Neuroscience News - November 12th, 2024 [November 12th, 2024]
- NeuroAI: A field born from the symbiosis between neuroscience, AI - The Transmitter: Neuroscience News and Perspectives - November 12th, 2024 [November 12th, 2024]
- The neuroscience of deeper learning in math - SmartBrief - November 12th, 2024 [November 12th, 2024]
- What the brain can teach artificial neural networks - The Transmitter: Neuroscience News and Perspectives - November 12th, 2024 [November 12th, 2024]
- How Anthony Zador thinks neuroscience can help improve AI - The Transmitter: Neuroscience News and Perspectives - November 12th, 2024 [November 12th, 2024]
- Discovering Cancer Therapies through Neuroscience - The New York Academy of Sciences - November 12th, 2024 [November 12th, 2024]
- Neuroscience Market Projected to Reach USD 50.2 Billion by 2032, Growing at a 4.0% CAGR S&S Insider - GlobeNewswire - November 12th, 2024 [November 12th, 2024]
- Insights on Brain Aging and Lifelong Cognitive Health - Neuroscience News - November 12th, 2024 [November 12th, 2024]
- A neuroscience PhD student at the University of Oxford has died - The Tab - November 12th, 2024 [November 12th, 2024]
- Exploring the connection between autism and sleep - The Transmitter: Neuroscience News and Perspectives - November 12th, 2024 [November 12th, 2024]
- Astrocytes star in memory storage, recall - The Transmitter: Neuroscience News and Perspectives - November 12th, 2024 [November 12th, 2024]
- Gut Bacteria Modulate Stress Responses Over Time - Neuroscience News - November 12th, 2024 [November 12th, 2024]
- Gut Bacteria Could Hold the Key to Promoting Healthy Aging - Neuroscience News - November 12th, 2024 [November 12th, 2024]
- Microglias pruning function called into question - The Transmitter: Neuroscience News and Perspectives - October 26th, 2024 [October 26th, 2024]
- Depression Alters Brain Circuits, Heightening Negative Perception - Neuroscience News - October 26th, 2024 [October 26th, 2024]
- UNE Researchers Showcase Groundbreaking Work at Global Neuroscience Conference - University of New England - October 26th, 2024 [October 26th, 2024]
- Scientists discover "glue" that holds memory together in fascinating neuroscience breakthrough - PsyPost - October 26th, 2024 [October 26th, 2024]
- Systems neuroscience: combining theory and neurotechnology for a multiscale account of the brain - Nature.com - October 26th, 2024 [October 26th, 2024]
- Seaport Therapeutics adds another $225 million to coffers to embrace the golden age of neuroscience - STAT - October 26th, 2024 [October 26th, 2024]
- ANRO Investors Have Opportunity to Join Alto Neuroscience, Inc. Fraud Investigation with the Schall Law Firm - Business Wire - October 26th, 2024 [October 26th, 2024]
- Youth Face Rising Risks of Harassment and Exploitation in the Metaverse - Neuroscience News - October 26th, 2024 [October 26th, 2024]
- Exercise During Chemotherapy Boosts Cognitive Function - Neuroscience News - October 26th, 2024 [October 26th, 2024]
- Removing Pre-Bed Screen Time Improves Toddler Sleep - Neuroscience News - October 26th, 2024 [October 26th, 2024]
- Bright Minds Biosciences and Firefly Neuroscience to Collaborate After the BREAKTHROUGH Study: A Phase 2 Trial of BMB-101 in Absence Epilepsy and... - October 26th, 2024 [October 26th, 2024]
- How Visual Clutter Disrupts Information Flow in the Brain - Neuroscience News - October 26th, 2024 [October 26th, 2024]
- Menopausal Hormone Therapys Effects on Brain Health - Neuroscience News - October 26th, 2024 [October 26th, 2024]
- After-hours movers: McDonald's, Starbucks, Seagate, Alto Neuroscience and more - StreetInsider.com - October 26th, 2024 [October 26th, 2024]